Trick or Treat? Background Searches Reveal the Truth! Follow the bouncing Ziacam ball. =====================================
To:Dan Zimmermann who wrote (4137)
From: Mad2 Wednesday, Jun 12, 2002 11:27 PM
Respond to of 4497
From Gumtech pertaining to Scio Nobels "study" on Zicam allergy relief
Disclosure Statement
The author Dr. Sion Nobel was employed by Barron Biotechnologies to conduct this study and serve as independent principal investigator. Barron Biotechnologies was contracted by Gumtech International, the manufacturer of Zicam Allergy Relief to organize a clinical allergy study with the drug. The author was paid a nominal fee based on patient enrollment in the study. Barron Biotechnologies is an independent company which has no vested interest in Gumtech. Barron Biotechnologies received some money but no stock or stock options from Gumtech as payment for the contract. No payments of any kind from Gumtech to Barron Biotechnologies or from Barron Biotechnologies to the author were ever dependent upon any outcomes.
Don't quite know who Barron Biotechnologies is, assume its a business of Ernesto Barron. Anyway its not a registered US business
mad2
--------------------------------------------------
knowx.com
4 Matches Found
Searching: Ernesto Barron | State: ALL
Purchase the Details:
OPTION 1: Buy for $19.95
OPTION 2: Buy Single Records for $9.95 (click on the record)
Results are sorted alphabetically by state. Scroll down to view.
RESIDENTIAL DESIGN & DRAFTING is a business entity in CA
BARRON BIOTECHNOLOGIES, LLC is a business entity in CA
INTERNATIONAL LEARNING CENTER, INC. is a business entity in MA
FRATERNAL ORDER OF EAGLES, TUCUMCARI AERIE #3526 is a business entity in NM
Modify Search | New Search
============================
1: Ear Nose Throat J. 2000 Oct;79(10):778-80, 782. Related Articles, Links
Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial.
Hirt M, Nobel S, Barron E.
Center of Integrative Medicine, Tarzana, Calif. 91356, USA.
Effective treatment for the common cold have been difficult to develop because so many different types of virus are responsible for this condition. Oral zinc has been studied as a possible means of preventing or alleviating symptoms, with mixed results. We studied a new approach to zinc therapy--an over-the-counter nasal gel formulation (Zicam)--to independently evaluate its efficacy as a treatment for the common cold. Our study was conducted at four sites over a 5-month period. The study group consisted of 213 patients with recent-onset(< or = 24) cold symptoms; 108 patients received zinc therapy, and 105 reviewed placebo. Symptom charts were used to track the duration and severity of each patient's symptoms. At study's end, the duration of symptoms was 2.3 days (+/-0.9)in the zinc group and 9.0 days (+/-2.5)in the control group--a statistically significant difference (p <0.05). These results provide evidence that zinc nasal gel is effective in shortening the duration of common cold symptoms off when taken within 24 hours of their onset.
Publication Types:
Clinical Trial
Randomized Controlled Trial
PMID: 11055098 [PubMed - indexed for MEDLINE] |
